# Sagene 2014 - Parkinson's Disease and Erectile Dysfunction

> **NCT02225548** · PHASE4 · UNKNOWN · sponsor: **University of South Florida** · enrollment: 10 (estimated)

## Conditions studied

- Parkinson's Disease
- Erectile Dysfunction

## Interventions

- **DRUG:** Selegiline
- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT02225548
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2018-12
- **Final completion:** 2019-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02225548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02225548, "Sagene 2014 - Parkinson's Disease and Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02225548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*